Non-GCB subtype of DLBCL with high Ki-67 index and overexpression of MYC and BCL2 proteins (double expression), insensitive to the standard first-line treatment show poor prognostic significance (31). The gene discussed is MKI67; the disease is diffuse large B-cell lymphoma.